Molecule
Brands
Company
Product Search
by Molecule
by Brands
by Company
NCE
Modified, Unique products
Recent KFDA Approval &
NHI enlisting
API Business info
Customer survey
Based on Production Vol.
DMF-Molecule, Status & Process
(Market & customer)
DMF Filling Status
Patent Status
My API profile Registration
Member's Lounge
General Market Information
KFDA registration process
DMF Filing
National Health Formulary enlisting
Law or Regulation
Major Pharmaceutical company
API importers directory
Distribution & Wholesaler
CRO & Other service Provider
Co-Biz Avenue
PharmaToday
Pharmaceutical Korea
Q & A
FAQ
General Q&A
Market Q&A
Business Inquiry
to Pharmalink
My Page
Company Registration
Company ID Management
Company Profile
Product description
>
API description
My Profile
Contacts in / out
General Q&A
Detail Information
Product Search
Detail Information
Xenobella 0.1 SD eye drop
Company
Chong Kun Dang
ETC/OTC
OTC
MOHSA Class
ATC
S01XA
NHI Price
502
Reg/Mark
Not sale
Unit
0.7mL/관, 30관/지함
Pill ID
(Front) (Back)
Composition
sodium hyaluronate 1.26mg
Indication
Dosage
(점안제)
다음 질환에 의한 각결막 상피장애 :
- 쇼그렌증후군, 피부점막안증후군(스티븐스-존슨증후군), 건성안증후군과 같은 내인성 질환
- 수술 후, 약제성, 외상, 콘텍트렌즈 착용 등에 의한 외인성 질환
1회 1방울 1일 5~6회 점안한다. 증상에 따라 적절히 증감한다.
점안 후 남은 액과 용기는 바로 버린다.
Xenobella 0.1 SD eye drop
[Close]
PharmaLink.kr
| Jin BD 2nd floor, Sadangdong 1039-59, Dongjak-Gu, Seoul
E-Mail :
pharmabase@nate.com
Tel : 82-70-7815-2200
Copyright ⓒ2013~2016 PharmaLink.Kr ALL RIGHTS RESERVED.